Author Reply: Therapeutic Drug Monitoring of Isavuconazole: Lessons Learnt from a Real-life Setting in a Tertiary Care Center in India
Parikshit Shirish Prayag
Keywords :
Fungal infections, Isavuconazole, Therapeutic drug monitoring
Citation Information :
Prayag P S. Author Reply: Therapeutic Drug Monitoring of Isavuconazole: Lessons Learnt from a Real-life Setting in a Tertiary Care Center in India. Indian J Crit Care Med 2023; 27 (6):451-451.
Patterson TF, Thompson GR, Denning DW, Fishman JA, Hadley S, Herbrecht R, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of America. Clin Infect Dis 2016;63(4):e1–e60. DOI: 10.1093/cid/ciw326.
Höhl R, Bertram R, Kinzig M, Haarmeyer GS, Baumgärtel M, Geise A, et al. Isavuconazole therapeutic drug monitoring in critically ill ICU patients: A monocentric retrospective analysis. Mycoses 2022;65(7):747–752. DOI: 10.1111/myc.13469.
Andes D, Kovanda L, Desai A, Kitt T, Zhao M, Walsh TJ. Isavuconazole concentration in real-world practice: Consistency with results from clinical trials. Antimicrob Agents Chemother 2018;62(7):e00585–e005818. DOI: 10.1128/AAC.00585-18.
